Arbutus Biopharma CEO to retire as company cuts workforce by 24%


The layoffs at Arbutus are tied to the company's decision in September to narrow its research focus in order to conserve cash.

Previous H.I.G. Capital portfolio company acquires Mexican chemical distributor
Next Chorus of business leaders again urge lawmakers to do more to reduce healthcare costs